| |
| | Dear Startup Investor,
The race for a COVID-19 vaccine has been dominating the news.
And with over 160 firms working night and day to develop a viable vaccine for the public...
One thing is clear...
This is the greatest biotech race of our generation.
In fact, the New York Times says this vaccine could be the most profitable drug in history.
Our projections show it could rake in $80 billion in revenue.
But even with an opportunity this massive, most people have no idea...
- WHICH company is pulling ahead in this vaccine race...
- WHOSE vaccine will likely reach the market first, and...
- WHEN it could arrive in your town.
Luckily, we have all of those bases covered for you.
Not only have we pinpointed one company that's moved ahead of the curve...
We're expecting them to release clinical trial results by June 30.
This company already got a MASSIVE infusion of cash last week... and the share price has been climbing at record speed.
Still, it pales in comparison to the anticipated impact of clinical trial results.
In total, our projections show that this event could spark a 3,000% stock surge when it's all said and done.
The thing is - you absolutely MUST be in by June 30.
That's less than 48 hours away.
So you NEED to drop whatever you're doing and watch this video ASAP.
All it took was one press release to send this stock haywire last week...
What do you think a working coronavirus vaccine would do to their share price?
I'll let you be the judge...
Click here to get the inside story.
Sincerely,
Bob Keppel Publisher, The Startup Investor
| Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team: Online Phone: 866-310-1498 (North America) 410-501-5876 (International) Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.
© 2020 Angels & Entrepreneurs. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.
Website | Privacy Policy | Terms & Conditionshttp://link.e.angelsandentrepreneurs.com/wf/unsubscribe?upn=SVR9z3LgXEwEIVbUkFIuhfIKPV96lSE9UseWeXZ52MI4WY4eEn-2FXQBTN4MGeOz0GseIyndgO8daCHIwjmPi0EySCaAsypuV8RNEMBC-2FVlkhIHWMm1hw0uSXu4GkwGu9TAayNV8TQjBBSMH1t8f3YsH-2BEq2eiGipWZqe-2B8-2FM83BW0PLWRHvzNABv2mbfX6aOkPLLd0EEA-2F9gmUacCRwUcygNFAXjLsLn5NeUTtdNr8YRyRccBvTgtwCQmd5e5idlqjDzCEPsdov2BiEA8NWXZRI-2FgJFYoq6fp4z7GazUe80l3jZILySYM2Lnmd26zyzmcL5BbOTpjDtZrGacP0wy4KT6T40MncprlMwmGHP5SKLIDZQh05aqRZDQmpFvZ4-2FtvnAY5NcV8zBjIulTAc5Au7YfGQLYvHs5oNywRr1-2B2Y1VTq-2F32TrWRE9F2qbL6DT1OBseGUTrWya7EHNUxfNrEk9TdGGYhaoqgw8O41peNbgC2azE5vdwfijgtspTb5KrPFe2HX9eAULTNZGxzpLq0DBA0SFX7WBD3tTQPvP8udJZSMA3ZQ2rnGNRaFpswPafbixeDsPPFGssHxl-2BlF-2F-2Buo7qcwOrvYdetE8cH0jq38jZCTXpghsgdU0oalWKZHgscunB-2F7VXfVdER0loMIl54RimHINjjFq5M7crZRyFImdVZkELtCKcSeiHws5cfiT-2BgGD1Try0EIgSAoSy-2BSNTTjJjcO2Wd4MGznV3mIVmTUxZcS2wkwzgb0hs80XanSBIgKKzQ4X5i1bqYmN1RR2nYgAZOmrt4ed5zxRZBwllSYWitrS03cUvWNCyWjRi12XZffgqKhaNCNU1n41HNqnUvCkvg1aM7nXYhhHxoyEZ9FUTNKE7Re0N96nyXlryz1ynGIENw9sct9zRKYfKItw6PH5KO3ozuYpYV06Z4Po4t6wZt3xJYZ-2Fdht7pxwDOxBrKcJCZsnxjQm6k5fCUwEG1CAFLYw8Cf3AnjMARM4AHS8aI-3D |
|
No comments:
Post a Comment